of fibrinogen, and possibly factor VII, in CAPD patients. Background. This study was performed to evaluate the relationship between serum albumin and plasma Key words: albumin, CAPD, factor VII, fibrinogen concentration of haemostatic factors and the effect of raising serum albumin on haemostatic factors synthesized in the liver in CAPD patients.
from the study. The median duration of CAPD was 16 albumin, and after 4 weeks of wash-out period. In the control group, the same parameters were measured three times months (range: 4-120 months). Forty patients suffered from diabetic nephropathy. Eighty-seven CAPD patients older without infusion of albumin. The individual regimen of dialysis and medications were maintained without significant than 40 years were evaluated for atherosclerotic cardiovascular disease. Atherosclerotic cardiovascular disease was change during the study period in all patients. considered to be present when one of the followings was observed: (i) positive thallium-SPECT with significant sten-Blood sampling and measurements osis on coronary angiography (>70%), (ii) ankle brachial index <0.9 with significant stenosis on doppler ultrasound Blood samples were obtained after an overnight fast. Serum of femoral or popliteal arteries, or (iii) presence of carotid albumin level was measured by bromcresol green method bruit with significant stenosis on doppler ultrasound of the using Hitachi a 736-40 autoanalyser (Hitachi Ltd, Tokyo, carotid arteries. The methodological details of thallium-Japan). Dialysate and urine albumin levels were measured SPECT and ankle brachial index were described in our by radioimmunoassay using commercially available kits previous report [5] . Thirty healthy volunteers (17 men, 13 (DPC, Los Angeles, CA). Serum triglyceride levels were women; median age 48 years, range 21-67 years) who were measured by an enzymatic method using Hitachi 736-40 considered to be free of cardiovascular disease based on autoanalyser and C-reactive protein was measured by nephhistory and physical examination were also included.
elometry. Serum samples were stored at −70°C for assay in batches which was performed within 1 week. All the kits for assay of haemostatic factors were purchased from
Study II
Diagnostica Stago (Asnieres-sur-seine, France). Plasma fibrinogen level was determined by the clotting method using Twenty-two CAPD patients with serum albumin level less STA-FibrinogenR. Factor II and Factor VII levels in plasma than 3.5 g/dl were included in the second study after were determined by the clotting method using STAR-Deficient obtaining informed consent. These patients were randomly II and STAR-Deficient VII, respectively. Plasma levels of assigned to the experimental and control groups. The clinical protein C and free protein S were measured by enzymecharacteristics of these two groups are shown in Table 1 .
linked immunosorbent assay (ELISA) using AsserachromR There were no differences in age, gender, duration of CAPD, Protein C and AsserachromR Free Protein S, respectpresence of diabetes, serum albumin, serum prealbumin, ively. Activity levels of plasminogen, a2-antiplasmin and Kt/V, residual renal function, and dialysate and urine albuantithrombin III were measured by the synthetic chromogenic min levels between these groups. To evaluate the total Kt/V substrate method using STAR-StachromR Plasminogen, urea index in CAPD patients, the sum of 24-h residual renal StachromR Antiplasmin and STAR-StachromR AT III, and dialytic urea clearances were divided by the urea distriburespectively. The inter-and intra-assay coefficients of varition volume which was calculated using Watson's normogram ation were 5.8% and 3.2% for fibrinogen, 9.7% and 7.9% for [7] . Residual renal function was estimated by the average of factor II, 11.1% and 5.7% for factor VII, 7.6% and 5.3% for the residual urea and creatinine clearances. Serum preprotein C, 8.2% and 3.1% for protein S, 8.7% and 1.3% albumin was measured using laser nephelometry.
for plasminogen, 10.4% and 4.3% for a2-antiplasmin, and The experimental group (n=11) received repeated infu-5.6% and 3.9% for antithrombin III, respectively (n=10). sions of albumin. The control group (n=11) was followed without infusion of albumin. The experimental group was administered 100 ml of 20% albumin solution three times per Statistical analysis week for 2 weeks. The plasma half-life of most haemostatic factors measured in our patients was less than 3-4 days [6 ] . Haemostatic factors and albumin are presented as Thus, two weeks of albumin infusion is approximately four mean±SD. Comparisons of these parameters between the times the half-life of haemostatic factors. Serum albumin, two groups were performed by Student's t test. The changes haemostatic factors, haematocrit, and C-reactive protein in haemostatic factors, albumin, haematocrit or CRP with were measured before, at the end of repeated infusion of repeated infusion or after withdrawal of albumin administration were evaluated by the paired t test. The correlations between haemostatic factors and albumin were evaluated (g/day)
Serum albumin was lower in diabetic patients (n=40)
Urine albumin (g/day) 0.4±0.6 0.3±0.4
(3.2±0.6 vs 3.5±0.6 g/dl, P<0.05), whereas plasma were not significant during the study period. Serum albumin, haematocrit and haemostatic factors in the control group did not change. CRP was stable during aP<0.001, bP<0.01.
the study period in both groups. fibrinogen was higher (559±140 vs 489±141 mg/dl, P<0.05).
Discussion
There was a significant inverse correlation between serum albumin and plasma fibrinogen levels (r= In several previous studies, haemostatic factors have −0.27, P<0.01). No correlation was found between been measured in small numbers of CAPD patients serum albumin and other haemostatic factors. There ( Table 4) . Increased fibrinogen level and factor VII were significant inverse correlations between triglyceractivity in patients on CAPD were consistent findings ides and albumin (r=0.24, P<0.05) and factor VII [8] [9] [10] [11] . Plasma concentration of free protein S was not (r=0.25, P<0.05), respectively. altered [8, 12] . The plasma concentration of antithrombin III in CAPD patients was reported to be higher Study II than in normal controls [9] , but the activity of antithrombin III was not different between CAPD The mean Kt/V of 22 hypoalbuminaemic patients was 2.12. There was no correlation between serum albumin patients and normal controls [8] . There is a controversy regarding plasma concentration or activity of factor and Kt/V. Serum albumin was significantly correlated with dialysate and total (dialysate+urine) albumin II, protein C, plasminogen and a2-antiplasmin [8,9,12].
The present study on a large number of CAPD patients loss, with correlation coefficients of 0.42 and 0.41, respectively (P<0.05). Mean prealbumin level of these confirms that fibrinogen level and factor VII activity are increased in CAPD patients. The differences in 22 patients in the second study was 32.3 mg/dl. Serum albumin level in 22 hypoalbuminaemic patients was other haemostatic factors between CAPD patients and normal subjects were not significant. 3.3±0.6 g/dl at the start of CAPD, which decreased to 2.7±0.3 during the months of CAPD.
Elevated plasma fibrinogen level and factor VII activity are also commonly encountered in patients The changes in serum albumin and haemostatic factors before, after repeated infusion of albumin, and with nephrotic syndrome [13] and end-stage renal disease on haemodialysis [14] . The link between after withdrawal of albumin are summarized in Table   Table 3 . Haemostatic factors at baseline, week 2 and week 6 in both experimental and control groups Albumin and haemostatic factors in CAPD patients 2057 hypoalbuminaemia and hyperfibrinogenaemia has been volume which results in the dilution of plasma haemostatic factors. Although the plasma volume was not suggested in nephrotic syndrome [15] , CAPD patients [5] and an animal model [16 ] . In this study, raising evaluated in this study, we measured haematorit as an indirect measure of plasma volume and corrected serum albumin by repeated infusion of albumin solution caused a significant fall in fibrinogen con-haemostatic factors accordingly.
Plasma fibrinogen is known to be an acute phase centration. Futhermore, with withdrawal of albumin infusion, fibrinogen level rebounded toward baseline reactant. In this study, C-reactive protein was also monitored as an index of acute phase reactivity and values. These findings suggest that hypoalbuminaemia is an important factor responsible for the increased changes in its level during the study period was not significant, suggesting that the changes in plasma fibplasma fibrinogen level in CAPD patients, too.
Factor VII did not correlate with albumin level, but rinogen of our patients were not due to an acute phase response. was influenced by albumin infusion. Absence of an inverse correlation may be partially explained by
In conclusion, the results of this study indicate that hypoalbuminemia is an important factor triggering the assuming that increased synthesis of factor VII is offset by peritoneal loss through dialysate with possibly elevation of plasma fibrinogen level, and possibly factor VII activity, in CAPD patients. This may contribute similar or higher clearance than albumin, considering that molecular weight (mol. wt) of albumin is approxi-to the frequent cardiovascular mortality observed in CAPD patients. mately 66 000 daltons and that of factor VII is 50 000 daltons.
